On October 18, 2022 McKesson reported that it will play a major role in the upcoming 2022 Association for Value-Based Cancer Care (AVBCC) Summit, speaking on a wide range of topics that showcase their extensive knowledge of the changing healthcare landscape and oncology’s transformation to value-based care (Press release, McKesson, OCT 18, 2022, View Source [SID1234622144]). The Summit, to be held Oct. 19-21, 2022, in New York City, is an invitational forum that provides invaluable access to more than 200 diverse experts representing every stakeholder of the cancer care ecosystem.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Staying ahead of the rapidly evolving landscape is challenging, and events like this greatly help, bringing together some of the best practices and ideas we can share to improve practice sustainability, clinical research and cancer care," said Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network. "We are committed to being at the forefront of value-based care and are excited to have the opportunity to collaborate with other thought leaders at this important meeting."

Summit participants will gain insights from a diverse range of practitioners, pharmacists, payers, policymakers and other key stakeholders who are nationally recognized in their fields. Attendees will learn strategies on how to stay competitive in the ever-changing field of oncology, explore cutting-edge methodologies enabling value-based care that can rapidly be implemented, and gain access to timely and accurate information from reliable sources to empower good decision-making. It facilitates achievable change by providing a forum for payers, providers and the entire oncology team to network and evaluate value in terms of quality, cost and impact on patient care and outcomes.

McKesson is represented at the Summit by several of its experts, speaking on a diverse array of topics including value-based agreements, oncology drug trends, pathways and decision support models. Summit sessions featuring affiliated speakers as panelists are:

Headwinds and Tailwinds Ahead for Value-Based Agreements (Oct. 19, 8:30 a.m.-9:30 a.m.)
Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network
Succeeding in Value-Based Payment Arrangements: ASCO (Free ASCO Whitepaper)’s Patient Centered Cancer Care Certification Pilot (Oct. 19, 10:30 a.m.-11:30 a.m.)
Matthew Skelton, MD, oncologist and physician champion for value-based care, Blue Ridge Cancer Care, a practice in The US Oncology Network
Legal and Regulatory Issues Surrounding Value-Based Agreements (Oct. 19, 2:15 p.m.-3:15 p.m.)
Ben Jones, vice president, Government Relations & Public Policy, The US Oncology Network
Lessons Learned from OCM That Should Be Incorporated into EOM and Future Cancer Care Models (Oct. 20, 9:45 a.m.-10:45 a.m.)
Marcus Neubauer, MD, chief medical officer, The US Oncology Network
How Long is the Last Mile? Real-World Evidence’s Vast Potential and Challenges in Oncology (Oct. 20, 3:15 p.m.-4 p.m.)
Viraj Narayanan, chief commercial officer, Ontada
Utilization of Pathways in Precision Medicine to Impact Patient Care (Oct. 21, 8 a.m.-9 a.m.)
Ira Zackon, MD, senior medical director, Ontada
The Impact Pathways Have on Outcomes and Value (Oct. 21, 10 a.m.-11 a.m.)
Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network, and Marcus Neubauer, MD, chief medical officer, The US Oncology Network
Oncology Drug Supply Channels and the Move to Smart Networks and Supporting Value-Based Agreements (Oct. 21, 10 a.m.-11 a.m.)
Heather Morel, PhD, president, Provider Solutions, McKesson
Practice Transformation Through Value-Based Analytics (Oct. 21, 11 a.m.-12 p.m.)
Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network
Payer and Provider Innovative Value-Based Agreement (Oct. 21, 2 p.m.-2:45 p.m.)
Rhonda Henschel, senior director, Payer Solutions, The US Oncology Network, and Jay Scott, director, Managed Care, Minnesota Oncology, a practice in The US Oncology Network
AI and ML Decision Support Models (Oct. 21, 2 p.m.-2:45 p.m.)
Ira Zackon, MD, senior medical director, Ontada
The live event is invitation-only, limiting the number of guests to adhere to COVID-19 safety guidelines; however, there will be a virtual simulcast of the entire Summit for those who cannot attend in person.